We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The National Academies of Sciences, Engineering and Medicine (NASEM) offered recommendations for creating opioid prescribing guidelines in a report released Thursday. Read More
The FDA yesterday proposed broadening its definition of the standard of evidence for effectiveness of investigational drugs and increasing the range of acceptable trial design, especially in rare disease research. Read More
The Association for Accessible Medicines said the changes “support open markets, greater competition and improved cost savings for patients.” Read More